Robert C. Green, MD, MPH is Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital and the Broad Institute. Dr. Green is an internationally recognized leader in developing research and policy to accelerate the implementation of genomic and precision medicine.
Education and Training: Dr. Green graduated from Amherst College and the University of Virginia School of Medicine, and earned a Masters of Public Health in epidemiology from Emory University School of Public Health. He obtained specialty training at Harvard Medical School residencies and is board certified in both neurology and medical genetics.
Research: Dr. Green led the first experimental trials disclosing common complex disease risk (REVEAL Study) and the first prospective studies of direct-to-consumer genetic testing services (PGen Study). He currently leads and co-leads the first NIH funded randomized trials to explore the implementation of medical sequencing in adults (MedSeq Project) and newborns (BabySeq Project), respectively, as well as the first sequencing studies in the active duty US military. His research has established the safety and feasibility of disclosing genetic risk information, assessing the impact of whole genome sequencing in primary care, creating the concept of aggregate penetrance of genomic variants in a prospective population cohort and demonstrating the safety and feasibility of genomic sequencing in healthy newborns. He has been continuously funded by NIH for 26 years and has published over 300 papers with an h-index of 80. In 2014, he won the Coriell Prize for Scientific Achievement in Personalized Medicine. Since joining the Harvard Medical School faculty in 2011, he and the G2P research team have been awarded federal and non-federal research totaling $31.7 million.
Research Administration: Dr. Green recently co-chaired the Steering Committee of both the Clinical Sequencing Exploratory Research program (18 NIH grants, over 300 investigators), and the Steering Committee of the Newborn Sequencing in Genomic Medicine and Public Health program (4 NIH grants, over 100 investigators) and is a co-investigator on the Partners site grants within the Electronic Medical Records and Genomics Network. He is Associate Director for Research of Partners HealthCare Personalized Medicine and is developing protocols for return of genomic results for the All of Us Research Program of the United States Precision Medicine Initiative and the Google/Verily Project Baseline.
Policy Leadership: Dr. Green was lead author on the influential recommendations for managing incidental findings in clinical sequencing from the American College of Medical Genetics and Genomics and contributing author on recommendations for managing incidental findings in research biobanks among participants and among family members of participants. He is a member of the National Academies of Science, Engineering and Medicine Committee on the “Evidence Base for Genetic Testing” and a Board Member of the Council for Responsible Genetics. He holds leadership positions within the Global Alliance for Genome Health and the All of Us Research Program on designing efforts to return research information, particularly genomic information, to research participants.
Presentations & Media: Scientific plenary presentations include the American College of Medical Genetics and Genomics, Cold Spring Harbor, World Congress of Psychiatric Genetics, Human Genome Variation Society, European Society for Human Genetics and BioData World. Presentations to business leaders include Forbes Healthcare Summit, World Science Festival, Future of Genomic Medicine, Exponential Medicine, Festival of Genomics, Aspen Ideas Festival, SXSW, Asian Healthcare Leadership and JP Morgan. His work and commentary have been featured on PBS television/radio, NBC Nightly News, CBS Sunday Morning, the Today Show, CNBC, the Doctors, the New York Times, the Wall Street Journal, Time Magazine, New Scientist, FastCompany, GenomeWeb, Gizmodo and Buzzfeed. Research findings from Genomes2People Research are highlighted in the following podcast, blog posts and on this video channel.